top of page

 PARTNERS 

EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D). 

OUR PARTNERS
Global network for worldwide impact

Gregory Fryer Associates Ltd.

United Kingdom

Gregory Fryer Associates Ltd.

​

Groupe de Recherche Action en Santé (GRAS)

Burkina Faso 

Groupe de Recherche Action en Santé (GRAS)

​

Hacettepe University

Turkey

Hacettepe University

​

Harvard School of Public Health

USA

Harvard School of Public Health

​

Health-Ecore B.V.

The Netherlands

Health-Ecore B.V.

​

Heidelberg University

Germany

Heidelberg University

​

Helmholtz Centre for Infection Research (HZI)

Germany

Helmholtz Centre for Infection Research (HZI)

​

Henogen Novasep

France

Henogen Novasep

​

Hospices Cantonaux CHUV

Switzerland

Hospices Cantonaux CHUV

​

Hospital of Lithuanian University of Health Sciences Kauno Klinikos

Lithuania

Hospital of Lithuanian University of Health Sciences Kauno Klinikos

​

Hvidovre Hospital

Denmark

Hvidovre Hospital

​

Hôpital National (DONKA)

Guinea

Hôpital National (DONKA)

​

IMAXIO SA

France

IMAXIO SA

​

Ifakara Health Institute (IHI)

Tanzania

Ifakara Health Institute (IHI)

​

ImmuneWatch BV

Belgium

ImmuneWatch BV

​

ImmunoVacc Consulting

Belgium

ImmunoVacc Consulting

​

Imperial College of Science Technology and Medicine London

United Kingdom

Imperial College of Science Technology and Medicine London

​

Infectious Diseases Research Institute (IDRI)

USA

Infectious Diseases Research Institute (IDRI)

​

Infrafrontier Gmbh

Germany

Infrafrontier Gmbh

​

Insilico Biotechnology AG

Germany

Insilico Biotechnology AG

​

Contact us

We'd love to hear from you!

For the latest updates follow EVI on:

  • LinkedIn
  • Twitter
  • YouTube
bottom of page